Stay updated on Dolutegravir Plus NRTIs in HIV-2 Clinical Trial

Sign up to get notified when there's something new on the Dolutegravir Plus NRTIs in HIV-2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dolutegravir Plus NRTIs in HIV-2 Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The update appears to be formatting/layout adjustments on the Study Details page without modifying core content (e.g., eligibility criteria, outcome measures, or study status). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-27T21:02:34.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Core content updated with a government funding notice and the NIH Clinical Center operating status, plus a version bump to v3.2.0.
    Difference
    3%
    Check dated 2025-10-06T08:12:06.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    - Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not imply substantive changes to content visible on the page.
    Difference
    0.1%
    Check dated 2025-09-29T04:48:18.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Version bump: v3.0.1 -> v3.0.2; the 'Back to Top' link was removed. No substantive changes to core content, pricing, or stock.
    Difference
    0.2%
    Check dated 2025-09-14T22:22:31.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T19:33:24.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The web page has been updated to include a new facility name and location in Lisbon, Portugal, along with a list of publications related to a clinical study on dolutegravir. Notably, previous references to certain location terms and related topics have been removed.
    Difference
    7%
    Check dated 2025-08-31T12:28:30.000Z thumbnail image

Stay in the know with updates to Dolutegravir Plus NRTIs in HIV-2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dolutegravir Plus NRTIs in HIV-2 Clinical Trial page.